Outcomes of CLL Patients Exposed to Venetoclax plus /-R after Ibrutinib in France: The Resist Retrospective Study from the Filo-CLL GroupLoic Ysebaert,Emmanuelle Ferrant,Marie Sarah Dilhuydy,Anne-Sophie Michallet,Luca Inchiappa,Romain Guieze,Emmanuelle Tchernonog, Ana Cavillon,Marie Christine Bene,Luc-Matthieu ForneckerBLOOD(2023)引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要